SEELQ·81577F109·US·equity·Healthcare - Biotechnology
CS
SEELQ (SEELOS THERAPEUTICS INC COM) is held by 0 institutional investors as of Q4 2024.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer